Korean Market
MATR
Celltrion
★
Celltrion to Acquire KRW 100 Billion Worth of Treasury Shares for Price Stabilization and Shareholder Value Enhancement
 05/21/2026, 11:09 AM
MATR
Celltrion
★
Free Stock Distribution of 10,920,342 Shares (0.05 per Share)
 05/21/2026, 11:09 AM
OWNR
Celltrion
★★
Celltrion Holdings Plans to Purchase Celltrion Shares Worth 100 Billion Won
 05/21/2026, 10:45 AM
PERI
Celltrion
★★★
Celltrion Q1 2026 Strong Results, Enhanced Shareholder Returns via Share Cancellation and Dividend
 05/15/2026, 05:22 PM
EXCH
Celltrion
★
CT-P55 (Cosentyx Biosimilar) US Phase 3 Trial Plan Amendment Approved by FDA
 05/12/2026, 01:40 PM
EXCH
Celltrion
★
Celltrion USA Amends Rights Offering: Total Amount Reduced, Second Payment Date Set
 05/11/2026, 04:41 PM
EXCH
Celltrion
★
Celltrion Invests Additional 516.1M USD in Subsidiary Celltrion USA
 05/11/2026, 04:38 PM
OTHR
Celltrion
★
Celltrion Reports Completion of Treasury Stock Acquisition
 05/08/2026, 10:01 AM
EXCH
Celltrion
★★★★
Decision to Cancel 488,977 Treasury Shares within Distributable Profits
 05/06/2026, 04:31 PM
EXCH
Celltrion
★★★★
Decision to Cancel 488,983 Treasury Shares to Enhance Shareholder Value
 05/06/2026, 08:30 AM
EXCH
Celltrion
★★
Celltrion Q1 2026 Operating Profit 321.9 Billion Won... Up 115% YoY
 05/06/2026, 08:28 AM
OWNR
Celltrion
★
Large shareholder extends 5 margin loans, repays 1
 05/04/2026, 04:59 PM
EXCH
Celltrion
★
CT-P6 SC (Herzuma subcutaneous) EU extension application - Phase 1 success
 05/03/2026, 07:00 AM
OWNR
Celltrion
★
Disclosure of Executive and Major Shareholder Securities Ownership (No Changes Reported)
 05/03/2026, 07:00 AM
OWNR
Celltrion
★
Filing of Ownership Report for Executives and Major Shareholders (No Content)
 05/03/2026, 07:00 AM